Celldex Therapeutics, Inc.
Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies

Last updated:

Abstract:

Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.

Status:
Grant
Type:

Utility

Filling date:

6 Aug 2020

Issue date:

9 Mar 2021